- Home
- AUTL vs BHK Comparison
AUTL vs BHK Comparison
Compare AUTL & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | BHK |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 665.2M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | BHK |
|---|---|---|
| Price | $1.46 | $9.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 315.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | ★ 28.33 | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $669.62 | N/A |
| Revenue Next Year | $79.78 | N/A |
| P/E Ratio | ★ N/A | $8.92 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.11 | $9.03 |
| 52 Week High | $2.70 | $11.00 |
Technical Indicators
Market Signals| Indicator | AUTL | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 33.06 |
| Support Level | $1.45 | N/A |
| Resistance Level | $1.52 | $9.72 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 13.51 | 28.07 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.